LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.

AstraZeneca PLC (LSE: AZN) Latest News

Investing Articles

I’d buy GlaxoSmithKline and AstraZeneca given this huge AI breakthrough

Despite the tepid market reaction, Jay Yao writes why he thinks the recent AI protein folding news is bullish for…

Read more »

Investing Articles

Here’s what I think the AstraZeneca vaccine means for the dividend

Jay Yao writes how he thinks AstraZeneca’s Covid-19 vaccine candidate could affect the company’s dividend payments in the coming years.

Read more »

Investing Articles

The top 2 UK shares I would buy today

As Christmas approaches, here are my top two UK shares I would pick up today.

Read more »

Investing Articles

What I think AstraZeneca’s purchase of Alexion means for the dividend

Jay Yao writes how he thinks AstraZeneca’s recent agreement to buy Alexion Pharmaceuticals affects the company’s dividend.

Read more »

Investing Articles

Can the AstraZeneca share price touch £100? 

The AstraZeneca share price has had a standout 2020. But is the best behind it or is there more to…

Read more »

Investing Articles

Why FTSE 100 firm AstraZeneca’s shares fell and Codemasters’ stock soared 20% today

FTSE 100 pharma giant AstraZeneca is seeing its share price fall today, but UK gaming stock Codemasters is flying on…

Read more »

Investing Articles

Will the AstraZeneca share price go back to £10 after the $39bn Alexion deal?

The AstraZeneca share price is down nearly 25% from July's record highs. But Roland Head reckons today's acquisition bid could…

Read more »

Investing Articles

The AstraZeneca share price: 3 things UK investors should know now

I'm optimistic about the long-term potential of the AstraZeneca share price, thanks to these three tailwinds that should help the…

Read more »

Investing Articles

AstraZeneca shares: should I buy now?

AstraZeneca shares have done well in recent years, but have not risen on the Covid-19 vaccine news. Edward Sheldon looks…

Read more »

Investing Articles

Why is the AstraZeneca share price down nearly 8% this week?

AstraZeneca's share price has fallen this week on concerns around the trial of the coronavirus vaccine it is developing with…

Read more »

Investing Articles

AstraZeneca shares: is the company a bargain after the vaccine candidate news?

Jay Yao discusses whether he thinks AstraZeneca is a bargain given the recent release of the company’s Covid-19 vaccine candidate…

Read more »

Investing Articles

At 8,000p, is FTSE 100 company AstraZeneca a share worth me buying right now?

If the R&D pipeline can keep powering yearly increases in earnings near 26%, as forecast for next year, I reckon…

Read more »